Annual EBITDA
-$41.82 M
+$22.46 M+34.94%
31 December 2022
Summary:
Calithera Biosciences annual earnings before interest, taxes, depreciation & amortization is currently -$41.82 million, with the most recent change of +$22.46 million (+34.94%) on 31 December 2022. During the last 3 years, it has risen by +$49.20 million (+54.06%). CALA annual EBITDA is now -442.68% below its all-time high of -$7.71 million, reached on 31 December 2012.CALA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$7.28 M
+$2.18 M+23.07%
31 December 2022
Summary:
Calithera Biosciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$7.28 million, with the most recent change of +$2.18 million (+23.07%) on 31 December 2022. CALA quarterly EBITDA is now -124.31% below its all-time high of -$3.25 million, reached on 30 September 2013.CALA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$41.82 M
+$10.99 M+20.81%
31 December 2022
Summary:
Calithera Biosciences TTM earnings before interest, taxes, depreciation & amortization is currently -$41.82 million, with the most recent change of +$10.99 million (+20.81%) on 31 December 2022. CALA TTM EBITDA is now -1188.32% below its all-time high of -$3.25 million, reached on 30 September 2013.CALA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CALA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +54.1% | +34.3% | +39.0% |
| 5 y5 years | +26.3% | +65.3% | +53.6% |
CALA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +54.1% | at high | +60.1% | at high | +39.0% |
| 5 y | 5 years | at high | +54.8% | at high | +70.8% | at high | +55.1% |
| alltime | all time | -442.7% | +54.8% | -124.3% | +70.8% | -1188.3% | +55.1% |
Calithera Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$41.82 M(-34.9%) | -$7.28 M(-23.1%) | -$41.82 M(-20.8%) |
| Sept 2022 | - | -$9.46 M(-16.3%) | -$52.81 M(-3.0%) |
| June 2022 | - | -$11.31 M(-17.8%) | -$54.42 M(-5.1%) |
| Mar 2022 | - | -$13.76 M(-24.7%) | -$57.35 M(-10.8%) |
| Dec 2021 | -$64.28 M(-29.4%) | -$18.27 M(+64.9%) | -$64.28 M(-6.3%) |
| Sept 2021 | - | -$11.08 M(-22.2%) | -$68.59 M(-14.6%) |
| June 2021 | - | -$14.23 M(-31.2%) | -$80.32 M(-7.4%) |
| Mar 2021 | - | -$20.69 M(-8.4%) | -$86.75 M(-4.7%) |
| Dec 2020 | -$91.02 M(-1.5%) | -$22.58 M(-1.0%) | -$91.02 M(+0.3%) |
| Sept 2020 | - | -$22.82 M(+10.4%) | -$90.78 M(+2.0%) |
| June 2020 | - | -$20.66 M(-17.2%) | -$88.98 M(-4.4%) |
| Mar 2020 | - | -$24.97 M(+11.8%) | -$93.10 M(+0.7%) |
| Dec 2019 | -$92.42 M(+62.8%) | -$22.34 M(+6.3%) | -$92.42 M(+2.5%) |
| Sept 2019 | - | -$21.01 M(-15.2%) | -$90.17 M(+1.8%) |
| June 2019 | - | -$24.79 M(+2.1%) | -$88.54 M(+31.4%) |
| Mar 2019 | - | -$24.28 M(+20.8%) | -$67.37 M(+18.7%) |
| Dec 2018 | -$56.78 M | -$20.09 M(+3.7%) | -$56.78 M(+18.0%) |
| Sept 2018 | - | -$19.38 M(+436.2%) | -$48.11 M(+36.3%) |
| June 2018 | - | -$3.61 M(-73.6%) | -$35.30 M(-5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$13.69 M(+19.7%) | -$37.33 M(+27.3%) |
| Dec 2017 | -$29.32 M(-22.9%) | -$11.43 M(+74.2%) | -$29.32 M(+6.9%) |
| Sept 2017 | - | -$6.56 M(+16.1%) | -$27.42 M(-6.8%) |
| June 2017 | - | -$5.65 M(-0.4%) | -$29.42 M(-13.8%) |
| Mar 2017 | - | -$5.68 M(-40.4%) | -$34.14 M(-10.2%) |
| Dec 2016 | -$38.04 M(+17.3%) | -$9.53 M(+11.3%) | -$38.04 M(+4.1%) |
| Sept 2016 | - | -$8.56 M(-17.5%) | -$36.55 M(-0.8%) |
| June 2016 | - | -$10.37 M(+8.4%) | -$36.85 M(+7.7%) |
| Mar 2016 | - | -$9.57 M(+19.0%) | -$34.23 M(+5.6%) |
| Dec 2015 | -$32.41 M(+51.8%) | -$8.04 M(-9.2%) | -$32.41 M(+4.2%) |
| Sept 2015 | - | -$8.86 M(+14.2%) | -$31.11 M(+13.6%) |
| June 2015 | - | -$7.75 M(-0.0%) | -$27.39 M(+9.4%) |
| Mar 2015 | - | -$7.76 M(+15.2%) | -$25.04 M(+17.2%) |
| Dec 2014 | -$21.36 M(+76.6%) | -$6.73 M(+31.0%) | -$21.36 M(+14.6%) |
| Sept 2014 | - | -$5.14 M(-5.0%) | -$18.64 M(+11.3%) |
| June 2014 | - | -$5.41 M(+32.7%) | -$16.75 M(+47.7%) |
| Mar 2014 | - | -$4.08 M(+1.5%) | -$11.34 M(+56.1%) |
| Dec 2013 | -$12.10 M(+57.0%) | -$4.02 M(+23.8%) | -$7.26 M(+123.8%) |
| Sept 2013 | - | -$3.25 M | -$3.25 M |
| Dec 2012 | -$7.71 M | - | - |
FAQ
- What is Calithera Biosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Calithera Biosciences?
- What is Calithera Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Calithera Biosciences?
- What is Calithera Biosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Calithera Biosciences?
What is Calithera Biosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CALA is -$41.82 M
What is the all time high annual EBITDA for Calithera Biosciences?
Calithera Biosciences all-time high annual earnings before interest, taxes, depreciation & amortization is -$7.71 M
What is Calithera Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CALA is -$7.28 M
What is the all time high quarterly EBITDA for Calithera Biosciences?
Calithera Biosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$3.25 M
What is Calithera Biosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CALA is -$41.82 M
What is the all time high TTM EBITDA for Calithera Biosciences?
Calithera Biosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is -$3.25 M